Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Bruker Launches aurora Elite ICP-MS

Published: Tuesday, February 26, 2013
Last Updated: Tuesday, February 26, 2013
Bookmark and Share
Company continue innovative products for trace elemental detection with launch of new aurora Elite.

At the recent European Winter Conference on Plasma Spectrochemistry 2013 (EWCPS), Bruker has launched the aurora Elite, a new ultra-sensitive Inductively Coupled Plasma Mass Spectrometer (ICP-MS).

Complementing the updated workhorse aurora M90 ICP-MS for routine laboratory analysis, the new aurora Elite sets unprecedented and truly exceptional standards for sensitivity and matrix robustness, even exceeding the performance of expensive magnetic sector field ICP-MS systems in many aspects, and far exceeding the sensitivity of all other quadrupole ICP-MS systems on the market.

The EWCPS conference focused on major topics of analytical plasma spectrochemistry, with Bruker experts and customers having presented a series of posters and talks illustrating the capabilities, applications and innovative design of both the further enhanced aurora M90 and the new addition to the Bruker ICP-MS family, the aurora Elite.

Topics covered by the posters and oral presentations included:
• 3D Ion Optics for ICP-MS
• Ion Optics for ICP-MS
• Mini Collision Cell for ICP-MS
• Isotope Ratio Determinations: High Sensitivity for Highest Precision
• Combining Highest Sensitivity with Selectivity for Quadrupole ICP-MS
• Advantages of High Sensitivity ICP-MS for Laser Ablation
• Measuring 26Mg/24Mg and 44Ca/40Ca Isotope Ratios in Environmental Samples by Q-ICP-MS
• Determination of Hg in Environmental Waters Using the Bruker aurora M90 in High Sensitivity Mode

The aurora Elite boasts a host of performance enhancements and new features, with unprecedented 1.5 gigahertz per parts per million (1.5 GHz / ppm) sensitivity for precise and accurate quantification at single digit ppt levels and below, which makes the aurora Elite the most sensitive ICP-MS instrument on the market.

This incredible sensitivity makes it eminently suitable for the semiconductor, geochemistry, materials science and related applications.

The lowest oxide ratios using its patented turner-interlaced coils ensures robust plasma conditions for complete matrix decomposition, all without the requirement of a plasma shield or guard electrode.

The combination of the aurora Elite’s high sensitivity with the all-digital detector delivers excellent results for isotope ratio determinations of low concentrations and for large ratios, and this is true for liquids and solids.

The combination of the aurora Elite’s GHz sensitivity with very short integration times makes this an ideal instrument for the analysis of nanoparticles at the smallest dimensions.

The incorporation of an easy-to-use Collision Reaction Interface (CRI II) provides a solution for simple, robust, maintenance-free interference challenges, with the convenience of either Helium- or Hydrogen mode, for improved detection limits of spectrally interfered isotopes and highest accuracy.

The expanded ICP-MS range from Bruker, including the enhanced aurora M90 and the new aurora Elite, now also offer 21 CFR Part 11 compliance to meet the requirements of pharmaceutical, biotech and CRO customers.

Dr. Meike Hamester, Director ICP-MS Global Market Development and Product Management at Bruker’s Chemical and Applied Markets (CAM) Division, commented: “The introduction of the most sensitive ICP-MS on the market provides an instrument that powers the business of quantification. Sensitivity is the key when low detection limits are the goal and the aurora Elite will be the enabler allowing trace elemental analysts to redefine their application boundaries.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PREMIER Biosoft Announces Reseller Agreement with Bruker
Agreement aims to advance lipidomics and metabolomics research.
Monday, November 17, 2014
Bruker Sells GC Business
Bruker completed the divestiture of its GC and GC single-quadrupole (GC-SQ) mass spectrometry products to Techcomp Europe Ltd on October 31st.
Tuesday, November 04, 2014
Using LC-MS to Analyse Sulfonamides in Food Grade Honey
Sulfonamides are one of a number of groups of chemicals whose presence in honey is limited by international regulations.
Tuesday, July 22, 2014
Bruker MALDI Biotyper™ Receives CFDA Clearance
Company receives clearance from the China Food and Drug Administration to market and sell its IVD MALDI Biotyper System as a medical device in China for the identification of microorganisms isolated from human specimens.
Thursday, June 26, 2014
Bruker Reports 7% Revenue Growth in Q4
Bruker Corporation reported financial results for its fourth quarter and full year ended December 31, 2013.
Wednesday, February 19, 2014
Bruker Granted FDA Clearance to Market the MALDI Biotyper CA System
Bruker able to market MALDI Biotyper CA System in the US for the identification of Gram negative bacterial colonies cultured from human specimens.
Tuesday, November 26, 2013
Bruker and SISCAPA Assay Technologies Announce Second-Phase Collaboration Agreement
The ongoing collaboration aims to exploit MALDI-TOF instruments as an alternative to nano-LC-MS technology currently used in many SISCAPA assays.
Monday, September 16, 2013
Bruker and ImaBiotech Announces Collaboration
Bruker to distribute ImaBiotech's Quantinetix software for quantitative MALDI imaging.
Friday, June 21, 2013
Bruker and 3M Sign Exclusive Patent License Agreement
The licensed 3M patents are directed to a technique for performing mass spectrometry analysis on proteins in tissue that has been preserved in paraffin.
Tuesday, June 04, 2013
Bruker and SCiLS GmbH Announce an Exclusive Partnership
SCiLS Lab is the software developed by SCiLS GmbH which allows the user-friendly statistical analysis of large MALDI imaging datasets.
Wednesday, May 15, 2013
Biodesix Announces Agreement with Bruker Daltonics
The collaborative agreement sees Bruker Daltonics support Biodesix’ VeriStrat diagnostic test as well as future diagnostic tests based on MALDI-TOF mass spectrometry.
Wednesday, April 24, 2013
Bruker and the Genome British Columbia Proteomics Centre to Collaborate
The collaborative effort covers the development and validation of high-throughput assays for determining hemoglobin variants and diabetes risk.
Thursday, April 18, 2013
Bruker and Erasmus Medical Center Sign an Exclusive Licensing Agreement
Agreement for adding rapid beta-lactamase testing capabilities to the MALDI Biotyper system.
Friday, January 04, 2013
Bruker Announces New UK Centre of Excellence
Company introduces its integrated, state-of-the-art demonstration, applications and customer collaboration facilities.
Wednesday, October 03, 2012
Bruker and JMI Laboratories Announce Collaboration for Mass Spectrometry
The collaboration sees Bruker and JMI Laboratories partner in the field of fungal identification by proteomics fingerprinting.
Wednesday, June 20, 2012
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Acetaldehyde and Formaldehyde Content in Foods
Korean researchers have determined the content of the toxic and carcinogenic aldehydes, acetaldehyde and formaldehyde, in a variety of food groups.
Combining the Power of Mass Spectrometry & Microscopy
A tool that provides world-class microscopy and spatially resolved chemical analysis shows considerable promise for advancing a number of areas of study, including chemical science, pharmaceutical development and disease progression.
Increasing Vitamin D Supplementation
New study from ETH Zurich finds that elderly women should consume more vitamin D than previously recommended during the winter months.
Advancing Lithium-Ion Battery Research
The increasing number of components in a lithium-ion battery makes it essential to use a variety of analytical methods to attain complete characterization.
Clearest Ever Images of Enzyme that Plays Key Roles in Aging, Cancer
UCLA-led research on telomerase could lead to new strategies for treating disease
Fruit Fly Pheromone Flags Great Real Estate for Starting a Family
Finding could aid efforts to control mosquito-borne diseases like malaria by manipulating odorants
Education and Expense: The Barriers to Mass Spectrometry in Clinical Laboratories?
Here we examine the perceived barriers to mass spec in clinical laboratories and explore the possible drivers behind the recent shift in uptake of the technology in clinical settings.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos